These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21527652)

  • 21. Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1996 Apr; 28(2):819. PubMed ID: 8623416
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of the new AxSYM cyclosporine assay: comparison with TDx monoclonal whole blood and Emit cyclosporine assays.
    Wallemacq PE; Alexandre K
    Clin Chem; 1999 Mar; 45(3):432-5. PubMed ID: 10053055
    [No Abstract]   [Full Text] [Related]  

  • 23. The new immunosuppressive malononitrilamide MNA 279 prolongs skin xenograft survival in a mouse-to-rat model.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1997 Dec; 29(8):3497-500. PubMed ID: 9414810
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients.
    Abou-Jaoude MM; Irani-Hakime N; Ghantous I; Najm R; Afif C; Almawi WY
    Transplant Proc; 2003 Nov; 35(7):2748-9. PubMed ID: 14612103
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimarães S
    Transplant Proc; 2000 Dec; 32(8):2623-5. PubMed ID: 11134730
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.
    Lucien J; Marath A; Rayat G; Thliveris J; Koshal A; Yatscoff R
    Transplant Proc; 1996 Apr; 28(2):704-7. PubMed ID: 8623356
    [No Abstract]   [Full Text] [Related]  

  • 27. FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patients.
    Fatio R; Sütsch G; Pei P; Follath F; Kiowski W
    Clin Chem; 1998 Mar; 44(3):693-4. PubMed ID: 9510894
    [No Abstract]   [Full Text] [Related]  

  • 28. Polyclonal/monoclonal ratio in kidney and bone marrow transplanted patients treated with cyclosporine.
    Capone D; De Marino V; Caso N; Stanziale P; Fontana R; Imperatore P; De Marino V; Pisanti N
    Clin Transplant; 1998 Oct; 12(5):430-3. PubMed ID: 9787953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine level: which single-point estimation of drug level is the best?
    Sharma R; Kumar J; Ahmed M; Gupta A; Gulati S; Sharma AP; Bhandari M
    Transplant Proc; 2001; 33(7-8):3124-5. PubMed ID: 11750343
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.
    Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Toze CL; Corr T; Currie C; Strong DK; Keown PA
    Transplant Proc; 1998 Aug; 30(5):1668-70. PubMed ID: 9723236
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].
    Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA
    Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
    Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
    West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.
    Hamwi A; Veitl M; Männer G; Ruzicka K; Schweiger C; Szekeres T
    Am J Clin Pathol; 1999 Sep; 112(3):358-65. PubMed ID: 10478141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia.
    Rodriguez V; Khan SP
    Transplant Proc; 2002 Jun; 34(4):1307-9. PubMed ID: 12072347
    [No Abstract]   [Full Text] [Related]  

  • 38. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay.
    Butch AW; Fukuchi AM
    J Anal Toxicol; 2004 Apr; 28(3):204-10. PubMed ID: 15107152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
    Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis and treatment of acquired aplastic anemia.
    Bacigalupo A; Passweg J
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):159-70. PubMed ID: 19327577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.